Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$2.88 - $8.51 $67,386 - $199,116
23,398 New
23,398 $152,000
Q2 2022

Aug 15, 2022

BUY
$1.81 - $8.93 $34,042 - $167,955
18,808 New
18,808 $36,000
Q2 2020

Aug 14, 2020

SELL
$9.02 - $15.12 $378,596 - $634,631
-41,973 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$7.14 - $16.86 $72,256 - $170,623
-10,120 Reduced 19.43%
41,973 $459,000
Q4 2019

Feb 14, 2020

BUY
$13.08 - $17.43 $681,376 - $907,980
52,093 New
52,093 $828,000

Others Institutions Holding VRCA

About Verrica Pharmaceuticals Inc.


  • Ticker VRCA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,094,100
  • Market Cap $327M
  • Description
  • Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...
More about VRCA
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.